These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3067657)

  • 1. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tamai Y; Taguchi F; Miura S
    Ann Neurol; 1988 Sep; 24(3):466-7. PubMed ID: 3067657
    [No Abstract]   [Full Text] [Related]  

  • 2. Proposal for a procedure for complete inactivation of the Creutzfeldt-Jakob disease agent.
    Taguchi F; Tamai Y; Uchida K; Kitajima R; Kojima H; Kawaguchi T; Ohtani Y; Miura S
    Arch Virol; 1991; 119(3-4):297-301. PubMed ID: 1877889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the Creutzfeldt-Jakob disease agent.
    Tateishi J; Tashima T; Kitamoto T
    Ann Neurol; 1988 Sep; 24(3):466. PubMed ID: 3067656
    [No Abstract]   [Full Text] [Related]  

  • 4. Demonstration of the transmissible agent in tissue from a pregnant woman with Creutzfeldt-Jakob disease.
    Tamai Y; Kojima H; Kitajima R; Taguchi F; Ohtani Y; Kawaguchi T; Miura S; Sato M; Ishihara Y
    N Engl J Med; 1992 Aug; 327(9):649. PubMed ID: 1640969
    [No Abstract]   [Full Text] [Related]  

  • 5. Newer data on the inactivation of scrapie virus or Creutzfeldt-Jakob disease virus in brain tissue.
    Brown P; Rohwer RG; Gajdusek DC
    J Infect Dis; 1986 Jun; 153(6):1145-8. PubMed ID: 3084671
    [No Abstract]   [Full Text] [Related]  

  • 6. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery.
    Bernoulli C; Siegfried J; Baumgartner G; Regli F; Rabinowicz T; Gajdusek DC; Gibbs CJ
    Lancet; 1977 Feb; 1(8009):478-9. PubMed ID: 65575
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral amyloid in mice with Creutzfeldt-Jakob disease is influenced by the strain of the infectious agent.
    Kitamoto T; Yi R; Mohri S; Tateishi J
    Brain Res; 1990 Jan; 508(1):165-7. PubMed ID: 2186845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium hydroxide decontamination of Creutzfeldt-Jakob disease virus.
    Brown P; Rohwer RG; Gajdusek DC
    N Engl J Med; 1984 Mar; 310(11):727. PubMed ID: 6422295
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical disinfection of Creutzfeldt-Jakob disease virus.
    Brown P; Gibbs CJ; Amyx HL; Kingsbury DT; Rohwer RG; Sulima MP; Gajdusek DC
    N Engl J Med; 1982 May; 306(21):1279-82. PubMed ID: 7040968
    [No Abstract]   [Full Text] [Related]  

  • 10. Conditions for the chemical and physical inactivation of the K. Fu. strain of the agent of Creutzfeldt-Jakob disease.
    Walker AS; Inderlied CB; Kingsbury DT
    Am J Public Health; 1983 Jun; 73(6):661-5. PubMed ID: 6342430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sterilization and disinfection.
    Neiburger EJ
    J Am Dent Assoc; 1992 Jul; 123(7):12, 15. PubMed ID: 1619153
    [No Abstract]   [Full Text] [Related]  

  • 12. Creutzfeldt-Jakob disease agent.
    Taylor DM
    Infect Control Hosp Epidemiol; 1988 Dec; 9(12):526. PubMed ID: 3069904
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of agent of Creutzfeldt-Jakob disease.
    Fallon RJ
    Br Med J; 1978 May; 1(6124):1418. PubMed ID: 348262
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter: Survival of Creutzfeldt-Jakob-disease virus in formol-fixed brain tissue.
    Gajdusek DC; Gibbs CJ
    N Engl J Med; 1976 Mar; 294(10):553. PubMed ID: 814460
    [No Abstract]   [Full Text] [Related]  

  • 15. Membrane filtration and the Creutzfeldt-Jakob agent.
    Taylor DM
    Lancet; 1985 Dec 21-28; 2(8469-70):1430-1. PubMed ID: 2867425
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoclaving does not decontaminate formol-fixed scrapie tissues.
    Taylor DM; McConnell I
    Lancet; 1988 Jun; 1(8600):1463-4. PubMed ID: 2455203
    [No Abstract]   [Full Text] [Related]  

  • 17. Isolation and characterization of the subacute spongiform virus encephalopathies of man: kuru and Creutzfeldt-Jakob disease.
    Gibbs CJ; Gajdusek DC
    J Clin Pathol Suppl (R Coll Pathol); 1972; 6():84-96. PubMed ID: 4218244
    [No Abstract]   [Full Text] [Related]  

  • 18. Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease.
    Connolly JH; Allen IV; Dermott E
    J Neurol Neurosurg Psychiatry; 1988 Nov; 51(11):1459-60. PubMed ID: 3069961
    [No Abstract]   [Full Text] [Related]  

  • 19. Subcellular distribution of the transmissible agent in Creutzfeldt-Jakob disease mouse brain.
    Tamai Y; Kojima H; Ohtani Y; Uchida K; Taguchi F; Kawaguchi T; Miura S; Tateishi J
    Microbiol Immunol; 1989; 33(1):35-42. PubMed ID: 2659945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical methods for chemical inactivation of Creutzfeldt-Jakob disease pathogen.
    Tateishi J; Tashima T; Kitamoto T
    Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1909414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.